Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Martek Biosciences

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences: Signs letter of intent to acquire a Winchester, Ky. fermentation facility for $10 mil. in cash, stock, and promissory notes from Golden Technologies Company. Martek plans to produce DHA (docosahexaenoic acid) and ARA (arachidonic acid) microbial triglyceride oils, the components of its Formulaid infant formula ingredient, at the plant. In December 1994, Martek received a patent for the DHA/ARA blend as well as blends used for supplementing infant formula such as ARA microbial oils with certain fish oils, and DHA microbial oils with vegetable oil sources of gamma linoleic acid. To date, American Home Products, Mead Johnson and Nutricia have signed license agreements with Martek to include Formulaid in their infant formulas, and Nutricia has launched a pre-term infant formula containing Formulaid in Belgium...

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

LL079488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel